New hope for advanced stomach cancer: drug cocktails under trial

NCT ID NCT05329766

Ongoing Disease control Sponsor: Arcus Biosciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study tests whether combining new drugs with or without chemotherapy can safely control advanced stomach, GEJ, or esophageal cancer. About 332 adults with inoperable or metastatic disease will receive different treatment combinations. The goal is to find more effective options that shrink tumors and extend life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma Of Esophagus digestive system cancer esophageal adenocarcinoma gastric adenocarcinoma gastric neoplasm gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL TRACT MALIGNANCIES

Contacts and locations

Locations

Research Site

Phoenix, Arizona, 85054, United States
Research Site

Los Angeles, California, 90033, United States
Research Site

Santa Monica, California, 90024, United States
Research Site

Derby, Connecticut, 06418, United States
Research Site

Fort Myers, Florida, 33901, United States
Research Site

Jacksonville, Florida, 32224, United States
Research Site

St. Petersburg, Florida, 33705, United States
Research Site

Boston, Massachusetts, 02109, United States
Research Site

New York, New York, 10021-0005, United States
Research Site

New York, New York, 10032, United States
Research Site

Durham, North Carolina, 27710, United States
Research Site

Columbus, Ohio, 43219, United States
Research Site

Oklahoma City, Oklahoma, 73104, United States
Research Site

Portland, Oregon, 97213, United States
Research Site

Nashville, Tennessee, 37203, United States
Research Site

Nashville, Tennessee, 37232, United States
Research Site

Fairfax, Virginia, 22031, United States
Research Site

Toronto, Canada
Research Site

Las Condes, Chile
Research Site

Recoleta, Chile
Research Site

Santiago, Chile
Research Site

Talca, Chile
Research Site

Bordeaux, France
Research Site

Brest, France
Research Site

Caen, France
Research Site

Lille, France
Research Site

Lyon, France
Research Site

Marseille, France
Research Site

Montpellier, France
Research Site

Plérin, France
Research Site

Poitiers, France
Research Site

Rouen, France
Research Site

Toulouse, France
Research Site

Villejuif, France
Research Site

Belgrade, Serbia
Research Site

Kamenitz, Serbia
Research Site

Kragujevac, Serbia
Research Site

Busan, South Korea
Research Site

Daegu, South Korea
Research Site

Hwasun, South Korea
Research Site

Seongnam-si, South Korea
Research Site

Seoul, South Korea
Research Site

Suwon, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.